Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, PDT, BFA, PSF

Blue Cross Blue Shield of Massachusetts Releases COVID-19 Vaccination Public Service Announcement Video


BOSTON, Jan. 25, 2021 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today released a new public health messaging video to support the COVID-19 vaccination effort. The 2-minute video, produced by Blue Cross' health news service Coverage, features Dr. Katherine Dallow, vice president of clinical programs and strategy at Blue Cross, sharing her perspective as a physician on the promise of the new vaccines.

"Public health experts have noted vaccine hesitancy may be a primary risk factor for COVID deaths in the next year," Dallow said. "Blue Cross is committed to sharing fact-based information about the safety and efficacy of FDA-authorized COVID-19 vaccines to help the public understand their benefit. Getting vaccinated against COVID-19 is one important step we can take to keep each other healthy, support our health care workers, and get Massachusetts businesses back on their feet."

Approximately 95% of Massachusetts residents are currently unvaccinated against the virus, which has infected nearly a half-million and killed nearly 14,000 in the state.

Blue Cross is covering the administration of all FDA-authorized COVID-19 vaccines, with no out-of-pocket cost for members.

As a public service, Blue Cross is making its PSA video available for republication free of charge for any media, governmental, educational, or public health messaging effort. See Coverage for more information about republishing this informational video.

About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts (www.bluecrossma.org) is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We are committed to the relentless pursuit of quality, affordable health care with an unparalleled consumer experience. Consistent with our promise to always put our members first, we are rated among the nation's best health plans for member satisfaction and quality. Connect with us on Facebook, Twitter, YouTube, and LinkedIn. BlueLinks for Employers

 

SOURCE Blue Cross Blue Shield of Massachusetts


These press releases may also interest you

at 09:35
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
United States Telehealth Weight Loss Market Report 2024-2028: Impacts of COVID and GLP-1 Meds Featuring Weight Watchers, Noom, Ro.co, , AmWell, Amazon, Teladoc, Form Health, Form Health Among Others - ResearchAndMarkets.com
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against QuidelOrtho Corporation
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

More news about Covid-19 virus...


News published on and distributed by: